Q & M Dental Group (Singapore) Limited (SGX:QC7)

Singapore · Delayed Price · Currency is SGD

0.5700

+0.0150 (2.70%)

Jul 21, 2026, 4:20 PM SGT

35.71% (1Y)

Market Cap	525.61M +32.3%
Revenue (ttm)	197.23M +9.2%
Net Income	9.31M -34.7%
EPS	0.01 -34.7%
Shares Out	947.04M
PE Ratio	56.43
Forward PE	35.28
Dividend	0.01 (1.52%)
Ex-Dividend Date	Mar 10, 2026

Volume	1,514,200
Open	0.5600
Previous Close	0.5550
Day's Range	0.5550 - 0.5750
52-Week Range	0.3900 - 0.6350
Beta	0.81
Analysts	Buy
Price Target	0.67 (+17.54%)
Earnings Date	Aug 12, 2026

About SGX:QC7

Q & M Dental Group (Singapore) Limited, an investment holding company, provides private dental healthcare services in Singapore, Malaysia, and China. It offers various aesthetic/cosmetic, pediatric, CAD CAM digital, children, clear aligner, and implant dentistry services; consultation, gum disease and surgery, intraoral 3D scanning, oral surgery, root canal treatment, scaling and polishing, teeth grinding and whitening, tooth-coloured filling, and wisdom tooth surgery services; and crowns and bridges, dental X-rays and AI scan, dentures, extrac... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1996

Employees 1,135

Stock Exchange Singapore Exchange

Ticker Symbol QC7

Full Company Profile

Financial Performance

In 2025, SGX:QC7's revenue was 197.23 million, an increase of 9.16% compared to the previous year's 180.67 million. Earnings were 9.31 million, a decrease of -34.72%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for QC7 stock is "Buy." The 12-month stock price target is $0.67, which is an increase of 17.54% from the latest price.

Price Target

$0.67

(17.54% upside)

Analyst Consensus: Buy

Stock Forecasts